Fig. 2From: Vitamin D receptor activator and prevention of cardiovascular events in hemodialysis patients—rationale and design of the Japan Dialysis Active Vitamin D (J-DAVID) trialLocations of the study sites. The colored areas indicate the 27 prefectures in which the 207 facilities were locatedBack to article page